Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2020-05-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine (Carlsbad Technology, Inc.), resulting in changes to its labeling.
-
FDA approval · 2020-05-04FDA Approved: ESOMEPRAZOLE — Original Application (INNOVUS PHARMACEUTICALS, INC.)
FDA approved Innovus Pharmaceuticals' original application for esomeprazole magnesium (Esomeprazole), a generic formulation.
-
FDA approval · 2020-04-30FDA Approved: OMEPRAZOLE, SODIUM BICARBONATE — Original Application (Guardian Drug Company)
FDA approved Guardian Drug Company's original application for omeprazole sodium bicarbonate, a generic proton pump inhibitor combination, fo…
-
FDA approval · 2020-04-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium (Ascend Laboratories) to bring a generic product to market.
-
FDA approval · 2020-04-01FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Gland Pharma Limited)
FDA approved the original application for esomeprazole sodium (generic) from Gland Pharma Limited, enabling its marketing in the United Stat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-03-25FDA Approved: OMEPRAZOLE — Original Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)
The FDA approves an original application for omeprazole (generic) submitted by Chain Drug Marketing Association, Inc., covering indications …
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for esomeprazole magnesium, a generic proton pump inhibitor.
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s Esomeprazole Magnesium as a generic version of esomeprazole under an Original Application (ANDA).
-
FDA approval · 2020-03-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Lifestar Pharma LLC.)
FDA approves a supplemental application to allow Lifestar Pharma LLC to market a generic version of lansoprazole.
-
FDA approval · 2020-02-21FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
The FDA approved a supplemental application for Walgreens' CIMETIDINE 200 ACID REDUCER, indicating approval of changes to the approved gener…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI) [Phase 2]
Phase 2 trial comparing vonoprazan to esomeprazole in symptomatic GERD patients who partly responded to high-dose PPIs; study completed with…
-
FDA approval · 2020-01-30FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company.
-
FDA label_change · 2020-01-07FDA Approved: FAMOTIDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA notes a supplemental application for famotidine by Lupin Pharmaceuticals, likely involving labeling changes for the drug.
-
FDA approval · 2020-01-03FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium from Lannett Company (ANDA 078281).
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Citalopram for Reflux Hypersensitivity and Functional Heartburn [Phase 4]
Phase 4 clinical trial update investigating citalopram for reflux hypersensitivity and functional heartburn in GERD patients.
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease [Phase 4]
Phase 4 clinical trial update for prucalopride in refractory gastro-esophageal reflux disease (GERD).
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
A completed clinical trial update focusing on the primary symptoms of gastroesophageal reflux disease in Chinese outpatients at a gastroente…
-
FDA approval · 2019-11-29FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for Rabeprazole sodium by Advagen Pharma Limited.
-
FDA approval · 2019-11-15FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for Rabeprazole sodium from Amneal Pharmaceuticals LLC (ANDA 204179).
-
FDA approval · 2019-11-14FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited.
-
FDA approval · 2019-11-14FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a Supplemental Application for Pantoprazole from NorthStar RxLLC, indicating an approved revision or addition to this generic p…
-
FDA approval · 2019-10-30FDA Approved: METOCLOPRAMIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for metoclopramide hydrochloride from Fresenius Kabi USA, LLC.
-
FDA approval · 2019-10-22FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
The FDA approved a supplemental application for ACID CONTROLLER (famotidine) submitted by H E B.
-
FDA approval · 2019-10-22FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., indicating changes or additions to the approved …
-
FDA approval · 2019-10-22FDA Approved: FAMOTIDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for famotidine by Aurobindo Pharma Limited under an ANDA, extending approval to include this manufac…